#JustPublished: an EMA overview of characteristics of #COVID19vaccines authorised in the 🇪🇺.
These include:
➡️technology platforms
➡️virus strains
➡️use as primary vaccination or booster
➡️population
https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#covid-19-vaccines:-strains,-use-and-age-ranges-(new)-section

🐦🔗: https://nitter.eu/EMA_News/status/1586991461026828289